Star Combo Pharma Ltd (S66.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -394 | -1,442 | -2,726 | -7,295 | -7,257 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -268 |
| Purchase Of Investment | -9,326 | N/A | -500 | N/A | N/A |
| Sale Of Investment | N/A | 1,305 | N/A | 4,050 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -3 | N/A | N/A |
| Investing Cash Flow | $-9,719 | $-137 | $-3,229 | $-3,244 | $-7,526 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 51 | -37 | -69 | -33 | -1,923 |
| Common Stock Issued | N/A | N/A | 77 | N/A | N/A |
| Dividend Paid | -500 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -346 | -334 | -62 | -136 | -161 |
| Financing Cash Flow | $-795 | $-371 | $-53 | $-169 | $-2,084 |
| Beginning Cash Position | 2,163 | 2,987 | 4,392 | 7,272 | 26,601 |
| End Cash Position | 3,590 | 2,163 | 2,987 | 4,392 | 17,322 |
| Net Cash Flow | $1,427 | $-824 | $-1,405 | $-2,880 | $-9,278 |
| Free Cash Flow | |||||
| Capital Expenditure | -394 | -1,442 | -2,729 | -7,295 | -7,257 |
| Free Cash Flow | -394 | -1,442 | -2,729 | -7,295 | -7,257 |